Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Febantel Market by Type (Purity 98%, Purity 99%, Other), By Application (Chemical Reagents, Pharmaceutical Intermediates, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Febantel Market by Type (Purity 98%, Purity 99%, Other), By Application (Chemical Reagents, Pharmaceutical Intermediates, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 138929 3300 Chemical & Material 377 234 Pages 4.6 (35)
                                          

Febantel is a broad-spectrum anthelmintic drug that is used to treat roundworm, hookworm, whipworm and tapeworm infections. It is also used as a deworming agent in animals. Febantel has been approved by the FDA for use in humans and animals. The global febantel market was valued at USD 1.2 billion in 2018 and is expected to reach USD 2.1 billion by 2030, growing at a CAGR of 5% from 2019 to 2030. Febantel is a drug used to treat roundworms in dogs. It is also used to treat hookworms and tapeworms in cats. Febantel is given orally, and it works by paralyzing the worms so they can be passed out of the body naturally.

Industry Growth Insights published a new data on “Febantel Market”. The research report is titled “Febantel Market research by Types (Purity 98%, Purity 99%, Other), By Applications (Chemical Reagents, Pharmaceutical Intermediates, Other), By Players/Companies Pure Chemistry Scientific, LGM Pharma, BOC Sciences, TCI, HBCChem, Toronto Research Chemicals, Texas Biochemicals, Waterstone Technology, 2A PharmaChem, 3B Scientific, J & K SCIENTIFIC, XiaoGan ShenYuan ChemPharm, Wuhan Fortuna Chemical, Shanghai Haoyuan Chemexpress, Shanghai Aladdin Bio-Chem Technology”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Febantel Market Research Report

By Type

Purity 98%, Purity 99%, Other

By Application

Chemical Reagents, Pharmaceutical Intermediates, Other

By Companies

Pure Chemistry Scientific, LGM Pharma, BOC Sciences, TCI, HBCChem, Toronto Research Chemicals, Texas Biochemicals, Waterstone Technology, 2A PharmaChem, 3B Scientific, J & K SCIENTIFIC, XiaoGan ShenYuan ChemPharm, Wuhan Fortuna Chemical, Shanghai Haoyuan Chemexpress, Shanghai Aladdin Bio-Chem Technology

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

234

Number of Tables & Figures

164

Customization Available

Yes, the report can be customized as per your need.


Global Febantel Industry Outlook


Global Febantel Market Report Segments:

The global Febantel market is segmented on the basis of:

Types

Purity 98%, Purity 99%, Other

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Chemical Reagents, Pharmaceutical Intermediates, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Pure Chemistry Scientific
  2. LGM Pharma
  3. BOC Sciences
  4. TCI
  5. HBCChem
  6. Toronto Research Chemicals
  7. Texas Biochemicals
  8. Waterstone Technology
  9. 2A PharmaChem
  10. 3B Scientific
  11. J & K SCIENTIFIC
  12. XiaoGan ShenYuan ChemPharm
  13. Wuhan Fortuna Chemical
  14. Shanghai Haoyuan Chemexpress
  15. Shanghai Aladdin Bio-Chem Technology

Global Febantel Market Overview


Highlights of The Febantel Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Purity 98%
    2. Purity 99%
    3. Other
  1. By Application:

    1. Chemical Reagents
    2. Pharmaceutical Intermediates
    3. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Febantel Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Febantel Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Febantel is a medication used to treat diarrhea. It is available as a tablet and as an injection. Febantel works by helping to restore the balance of bacteria in the intestines. This can help relieve symptoms of diarrhea, such as cramps, bloating, and nausea. Febantel may also be used to prevent or treat Clostridium difficile (C. diff) infection.

Some of the key players operating in the febantel market are Pure Chemistry Scientific, LGM Pharma, BOC Sciences, TCI, HBCChem, Toronto Research Chemicals, Texas Biochemicals, Waterstone Technology, 2A PharmaChem, 3B Scientific, J & K SCIENTIFIC, XiaoGan ShenYuan ChemPharm, Wuhan Fortuna Chemical, Shanghai Haoyuan Chemexpress, Shanghai Aladdin Bio-Chem Technology.

The febantel market is expected to register a CAGR of 5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Febantel Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Febantel Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Febantel Market - Supply Chain
   4.5. Global Febantel Market Forecast
      4.5.1. Febantel Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Febantel Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Febantel Market Absolute $ Opportunity

5. Global Febantel Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Febantel Market Size and Volume Forecast by Type
      5.3.1. Purity 98%
      5.3.2. Purity 99%
      5.3.3. Other
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Febantel Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Febantel Market Size and Volume Forecast by Application
      6.3.1. Chemical Reagents
      6.3.2. Pharmaceutical Intermediates
      6.3.3. Other
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Febantel Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Febantel Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Febantel Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Febantel Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Febantel Demand Share Forecast, 2019-2029

9. North America Febantel Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Febantel Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Febantel Market Size and Volume Forecast by Application
      9.4.1. Chemical Reagents
      9.4.2. Pharmaceutical Intermediates
      9.4.3. Other
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Febantel Market Size and Volume Forecast by Type
      9.7.1. Purity 98%
      9.7.2. Purity 99%
      9.7.3. Other
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Febantel Demand Share Forecast, 2019-2029

10. Latin America Febantel Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Febantel Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Febantel Market Size and Volume Forecast by Application
      10.4.1. Chemical Reagents
      10.4.2. Pharmaceutical Intermediates
      10.4.3. Other
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Febantel Market Size and Volume Forecast by Type
      10.7.1. Purity 98%
      10.7.2. Purity 99%
      10.7.3. Other
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Febantel Demand Share Forecast, 2019-2029

11. Europe Febantel Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Febantel Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Febantel Market Size and Volume Forecast by Application
      11.4.1. Chemical Reagents
      11.4.2. Pharmaceutical Intermediates
      11.4.3. Other
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Febantel Market Size and Volume Forecast by Type
      11.7.1. Purity 98%
      11.7.2. Purity 99%
      11.7.3. Other
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Febantel Demand Share, 2019-2029

12. Asia Pacific Febantel Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Febantel Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Febantel Market Size and Volume Forecast by Application
      12.4.1. Chemical Reagents
      12.4.2. Pharmaceutical Intermediates
      12.4.3. Other
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Febantel Market Size and Volume Forecast by Type
      12.7.1. Purity 98%
      12.7.2. Purity 99%
      12.7.3. Other
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Febantel Demand Share, 2019-2029

13. Middle East & Africa Febantel Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Febantel Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Febantel Market Size and Volume Forecast by Application
      13.4.1. Chemical Reagents
      13.4.2. Pharmaceutical Intermediates
      13.4.3. Other
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Febantel Market Size and Volume Forecast by Type
      13.7.1. Purity 98%
      13.7.2. Purity 99%
      13.7.3. Other
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Febantel Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Febantel Market: Market Share Analysis
   14.2. Febantel Distributors and Customers
   14.3. Febantel Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Pure Chemistry Scientific
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. LGM Pharma
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. BOC Sciences
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. TCI
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. HBCChem
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Toronto Research Chemicals
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Texas Biochemicals
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Waterstone Technology
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. 2A PharmaChem
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. 3B Scientific
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. J & K SCIENTIFIC
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. XiaoGan ShenYuan ChemPharm
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. Wuhan Fortuna Chemical
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. Shanghai Haoyuan Chemexpress
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. Shanghai Aladdin Bio-Chem Technology
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us